- Home
- LSB vs CLNN Comparison
LSB vs CLNN Comparison
Compare LSB & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- CLNN
- Stock Information
- Founded
- LSB 2002
- CLNN 2012
- Country
- LSB China
- CLNN United States
- Employees
- LSB N/A
- CLNN N/A
- Industry
- LSB
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- LSB
- CLNN Health Care
- Exchange
- LSB NYSE
- CLNN Nasdaq
- Market Cap
- LSB 20.4M
- CLNN 23.1M
- IPO Year
- LSB N/A
- CLNN N/A
- Fundamental
- Price
- LSB $1.04
- CLNN $3.78
- Analyst Decision
- LSB
- CLNN Strong Buy
- Analyst Count
- LSB 0
- CLNN 5
- Target Price
- LSB N/A
- CLNN $40.00
- AVG Volume (30 Days)
- LSB 841.1K
- CLNN 45.1K
- Earning Date
- LSB 07-29-2025
- CLNN 08-06-2025
- Dividend Yield
- LSB N/A
- CLNN N/A
- EPS Growth
- LSB N/A
- CLNN N/A
- EPS
- LSB N/A
- CLNN N/A
- Revenue
- LSB $79,415,311.00
- CLNN $350,000.00
- Revenue This Year
- LSB $39.33
- CLNN N/A
- Revenue Next Year
- LSB $75.61
- CLNN $1,753.57
- P/E Ratio
- LSB N/A
- CLNN N/A
- Revenue Growth
- LSB N/A
- CLNN N/A
- 52 Week Low
- LSB $0.36
- CLNN $2.28
- 52 Week High
- LSB $6.82
- CLNN $6.96
- Technical
- Relative Strength Index (RSI)
- LSB 48.03
- CLNN 51.44
- Support Level
- LSB $1.01
- CLNN $3.53
- Resistance Level
- LSB $1.16
- CLNN $3.98
- Average True Range (ATR)
- LSB 0.12
- CLNN 0.18
- MACD
- LSB 0.01
- CLNN -0.03
- Stochastic Oscillator
- LSB 20.00
- CLNN 56.14
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.